三种治疗高血压药物的成本-效果分析  

Cost-effectiveness Analysis of Three Antihypertension Agents

作　　者：任非[1] 智丽敏[1] 韩天顺[1] 王秉臣[1] 

机构地区：[1]河北医科大学第二医院,石家庄050000

出　　处：《中国现代应用药学》2006年第S2期817-818,共2页Chinese Journal of Modern Applied Pharmacy

摘　　要：目的对3种治疗高血压药物进行经济学评价。方法运用成本-效果分析法对氨氯地平、非洛地平、缓释硝本地平的疗效及成本进行比较。结果3组成本-效果比分别为1.14、0.81、0.78。结论缓释硝本地平为最佳方案。OBJECTIVE To evaluate the pharmacoeconomic effectiveness of three antihypertension agents.METHODS Using cost-effectiveness analysis,three agents were compared for effect and costs.RESULTS The cost-effectiveness ratios of three group were 1.14,0.81 and 0.78.CONCLUSION Nifedipine Sustained Release Tablets is the best one.

关 键 词：高血压 氨氯地平 非洛地平 缓释硝本地平 成本-效果分析 

分 类 号：R544.1[医药卫生—心血管疾病]